You have 9 free searches left this month | for more free features.

recurrent adult brain tumor

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Malignant Glioma, Brain Tumor, Recurrent Trial in Durham (D2C7-IT)

Active, not recruiting
  • Malignant Glioma
  • Brain Tumor, Recurrent
  • Durham, North Carolina
    Preston Robert Tisch Brain Tumor Center at Duke
Jul 12, 2022

Refractory Cancer, CNS Tumors, CNS Tumor, Adult Trial in Atlanta, New York (Avutometinib)

Recruiting
  • Refractory Cancer
  • +14 more
  • Atlanta, Georgia
  • +1 more
Oct 23, 2023

Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, Recurrent CNS Tumor, Adult Trial in Seattle (SC-CAR4BRAIN)

Not yet recruiting
  • Diffuse Intrinsic Pontine Glioma
  • +4 more
  • SC-CAR4BRAIN
  • Seattle, Washington
    Seattle Children's Hospital
Mar 3, 2023

Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma Trial in Duarte (biological,

Completed
  • Adult Anaplastic Astrocytoma
  • +6 more
  • E. coli CD-expressing genetically modified neural stem cells
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Sep 28, 2021

Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma Trial in United States (bevacizumab, radiation therapy)

Completed
  • Adult Giant Cell Glioblastoma
  • +3 more
  • bevacizumab
  • radiation therapy
  • Birmingham, Alabama
  • +30 more
Dec 27, 2022

Brain Tumor, Recurrent, Adult Trial in Loma Linda (PET/CT with F-Fluciclovine (Axumin))

Recruiting
  • Brain Tumor, Recurrent, Adult
  • PET/CT with F-Fluciclovine (Axumin)
  • Loma Linda, California
    Loma Linda University Cancer Center
Sep 20, 2021

Glioblastoma, Glioblastoma Multiforme, Glioblastoma Multiforme, Adult Trial in Phoenix (Pamiparib, Olaparib, Radiation therapy)

Recruiting
  • Glioblastoma
  • +2 more
  • Phoenix, Arizona
    St. Joseph's Hospital and Medical Center
May 3, 2022

Adult Diffuse Astrocytoma, Adult Mixed Glioma, Adult Oligodendroglioma Trial in Los Angeles (tumor lysate-pulsed autologous

Completed
  • Adult Diffuse Astrocytoma
  • +4 more
  • tumor lysate-pulsed autologous dendritic cell vaccine
  • laboratory biomarker analysis
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Oct 14, 2020

Adult Brain Tumor, Adult Brain Stem Glioma, Adult Diffuse Astrocytoma Trial in Philadelphia (radiation, procedure, other)

Completed
  • Adult Brain Tumor
  • +11 more
  • proton beam radiation therapy
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of The University of Pennsylvania
Dec 8, 2020

Recurrent World Health Organization (WHO) Grade II Glioma Trial in United States (Everolimus, Trametinib)

Recruiting
  • Recurrent World Health Organization (WHO) Grade II Glioma
  • Birmingham, Alabama
  • +11 more
May 6, 2022

Ependymoma, Glioblastoma, Medulloblastoma Trial in Duarte (IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR

Recruiting
  • Ependymoma
  • +3 more
  • IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR Truncated CD19-expressing Autologous T-Lymphocytes
  • Duarte, California
    City of Hope Medical Center
Mar 9, 2022

Low Grade Glioma of Brain Trial in Durham (PEPIDH1M vaccine + vorasidenib)

Not yet recruiting
  • Low Grade Glioma of Brain
  • PEPIDH1M vaccine + vorasidenib
  • Durham, North Carolina
    Duke University Medical Center
Nov 2, 2022

Pediatric Brain Tumor, Recurrent Pediatric Brain Tumor, Pediatric Supratentorial Tumor Trial in San Francisco (Universal Donor

Not yet recruiting
  • Pediatric Brain Tumor
  • +2 more
  • Universal Donor (UD) Transforming growth factor beta imprinting (TGFβi) Natural Killer (NK) Cells
  • Implantation
  • San Francisco, California
    University of California, San Francisco
May 24, 2023

Brain Tumor Recurrent Trial in Houston (Methotrexate, Etoposide, Ommaya Reservoir)

Recruiting
  • Brain Tumor Recurrent
  • Houston, Texas
    UTHealth & Children's Memorial Hermann Hospital
Aug 17, 2022

Melanoma, Non-small Cell Lung Carcinoma (NSCLC), Renal Cell Carcinoma (RCC) Trial in Gainesville, Jacksonville (LITT +

Recruiting
  • Melanoma
  • +14 more
  • LITT + Pembrolizumab
  • Gainesville, Florida
  • +1 more
Aug 22, 2022

Primary Brain Tumor, Brain Tumor, Recurrent Trial in Durham (Fluoxetine, Temozolomide)

Not yet recruiting
  • Primary Brain Tumor
  • Brain Tumor, Recurrent
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke University
Dec 20, 2022

AI R&D Tool in Adult Glioma and Other Primary Brain Tumours

Not yet recruiting
  • Brain Tumor
  • +4 more
  • Resection
  • London, United Kingdom
    Imperial College Healthcare NHS Trust
Sep 15, 2023

Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma Trial in Cincinnati, Cleveland (biological, device, other)

Completed
  • Adult Giant Cell Glioblastoma
  • +3 more
  • Bevacizumab
  • +2 more
  • Cincinnati, Ohio
  • +2 more
Jul 22, 2020

Brain Tumor, Recurrent, Brain Tumor, Pediatric, CNS Tumors Trial in Houston (RRx-001, Temozolomide, Irinotecan)

Recruiting
  • Brain Tumor, Recurrent
  • +3 more
  • Houston, Texas
    Texas Children's Cancer Center
Aug 15, 2022

Pediatric Brain Tumor Trial in Boston (HIIT Exercise Program, Control Group)

Not yet recruiting
  • Pediatric Brain Tumor
  • HIIT Exercise Program
  • Control Group
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Feb 13, 2023

Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)

Active, not recruiting
  • Brain Tumor
  • +12 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 20, 2022

Glioma, Glioma, Malignant, Glioblastoma Trial in New York (Laparoscopically harvested omental tissue autograft)

Recruiting
  • Glioma
  • +7 more
  • Laparoscopically harvested omental tissue autograft
  • New York, New York
    Lenox Hill Brain Tumor Center
Jul 31, 2023

NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +32 more
  • (no location specified)
Mar 30, 2023